Promino Nutritional Sciences Inc Stock Price, News & Analysis

Promino Nutritional Sciences (MUSLF) has extended its partnership with Fastbreak AI through summer 2025, following successful initial activations that boosted direct-to-consumer sales. The company recently participated in The Penn Relays, which attracts over 120,000 athletes, coaches, and parents nationwide. This marks the first of five Fastbreak-organized events Promino will attend in 2025. Promino's NSF Certified for Sport® protein drink features low calories, no sugar, no dairy, and is plant-based. The partnership leverages Fastbreak Connect, an AI-driven platform that reaches 850,000+ youth athletes annually and operates at 10,000+ tournaments across the US. The collaboration includes product sampling, athlete content capture, on-site retail promotions, and exclusive offers through Fastbreak's digital engagement programs.

Promino Nutritional Sciences (CSE: MUSL) (OTC Pink: MUSLF) has announced that its flagship product Promino™ has been named the Official Protein Drink of the Vegas Knight Hawks, a professional Indoor Football League team. The partnership, signed on April 15, 2025, marks a strategic expansion in the U.S. market, particularly in Las Vegas.

The agreement adds to Promino's growing presence in Las Vegas sports, joining existing partnerships with Team Promino athlete José Bautista's Las Vegas Lights FC and Vegas Golden Knights player Jack Eichel. Promino™, an NSF Certified for Sport® product, is a clinically validated muscle activator designed for enhanced muscle recovery and strength without dairy-based proteins.

The brand will be integrated into arena promotions, digital campaigns, and team training environments as part of this strategic partnership.

Promino Nutritional Sciences (CSE: MUSL, OTC: MUSLF) has initiated its second preclinical study to evaluate how its patented essential amino acid (EAA) blend affects muscle preservation during chemotherapy for breast and prostate cancer patients.

The research, led by Dr. Patrick Gunning, Chief Scientific Advisor to Promino and Professor of Medicinal Chemistry and Molecular Therapeutics at the University of Toronto and University of Glasgow, will use murine models to study the blend's effectiveness in preventing cachexia (severe muscle loss) during chemotherapy treatment.

The study targets breast cancer, affecting over 2.3 million women annually, and prostate cancer, impacting 1.4 million men yearly. The company's EAA formulation, developed by Dr. Robert Wolfe of the University of Arkansas, is designed to stimulate muscle protein synthesis during metabolic stress. Results from these preclinical trials will guide future human studies and potential clinical collaborations with North American oncology institutions.

Promino Nutritional Sciences (OTC: MUSLF) reported significant revenue growth through Amazon.com, increasing from US$1,500 in December 2024 to US$99,700 in Q1 2025, marking a 36x increase. The company's monthly revenue progression showed:

• December 2024: US$1,500
• January 2025: US$9,500
• February 2025: US$35,200
• March 2025: US$55,000

The growth is driven by two plant-based protein muscle health products: Rejuvenate Muscle Activator, selling over 1,600 units monthly, and Promino NSF Certified for Sport, reaching 100+ units monthly. The company expects approximately 60% gross margin from this revenue stream. Success is attributed to digital marketing investments and a national high school athletics sampling program.

Promino Nutritional Sciences (CSE: MUSL) (OTC: MUSLF) has announced breakthrough research showing that one serving of their patented Promino™ formula equals 75 grams of whey protein in stimulating muscle protein synthesis (MPS).

The research highlights that whey protein's effectiveness diminishes beyond 40g servings, with MPS plateauing at 20-25g per serving. In contrast, Promino™ utilizes a precision-engineered Essential Amino Acid (EAA) formulation that maximizes MPS with minimal waste, offering a more efficient and digestion-friendly alternative to traditional protein supplementation.

The product, which is NSF Certified for Sport®, has gained endorsement from elite athletes including Jose Bautista, Jack Eichel, and Kirk McLean. The company positions Promino™ as a revolutionary sports nutrition solution that delivers superior muscle support with less volume and zero digestive discomfort.

Promino Nutritional Sciences (CSE: MUSL) (OTC: MUSLF) has expanded its U.S. distribution network by adding Cub Foods, an 80-store supermarket chain in Minnesota and Illinois, as a new retail partner for its Rejuvenate Muscle Activator product.

This expansion follows recent partnerships with The Giant Company, Big Y, and Jean Coutu, as well as online retailers Vitacost and iHerb, and three national food and beverage distributors. The product is now available at nearly 100,000 retailers across the United States.

In January 2025, Rejuvenate Muscle Activator achieved significant success on Amazon.com, selling approximately 1,000 units and ranking in the top 100 of Amazon's Protein Supplements bestsellers list.

Promino Nutritional Sciences (CSE: MUSL) (OTC Pink: MUSLF) has announced a private placement financing to raise up to $750,000. The company will offer units at $0.05 each, with each unit consisting of one common share and one purchase warrant. The warrants will be exercisable at $0.18 per share for a 24-month period from issuance.

All securities issued will have a statutory hold period of four months and one day. Promino may pay finder's fees in accordance with applicable securities laws and Canadian Securities Exchange policies. The offering requires customary conditions and necessary approvals, including CSE acceptance.

The company plans to use the net proceeds to accelerate sales and fulfillment of its sports beverages, Promino™ and Rejuvenate Muscle™ Health, settle outstanding liabilities, and for general working capital purposes.

Promino Nutritional Sciences (CSE: MUSL) (OTC: MUSLF) reports significant growth for its Rejuvenate Muscle Activator product on Amazon.com. The supplement achieved a 500% increase in units sold in January 2025, maintaining approximately 60% gross margins and reaching #67 in Amazon's Protein Supplements ranking.

The product is specifically formulated for individuals using GLP-1 drugs for weight loss and bariatric patients. Key features include: only 5 calories per serving, dairy-free, sugar-free, plant-based, keto-friendly, and vegan composition. The company states one serving builds equivalent muscle as 40g of whey protein isolate. Monthly unit sales are projected to reach 1,000 in February 2025.

Promino Nutritional Sciences (CSE: MUSL) (OTC: MUSLF) has announced a partnership with Fastbreak AI for four sampling events in February 2025. The events include the Boys Winter Invitational, MyHockey Tampa Presidential Power Play, North American Youth Football Championships, and USA Volleyball Florida Region.

Through these events, Promino will distribute over 3,000 samples of their NSF Certified for Sport® product to athletes and create media content. The partnership leverages Fastbreak Connect's platform, which already hosts brands like adidas and Gatorade, reaching over 850,000 athletes and users.

Additionally, the company has entered into advisory agreements for direct-to-consumer marketing and business re-commercialization efforts. As compensation, advisors will receive 800,000 common shares issued in tranches over an 18-month term, subject to a four-month statutory hold period.